ReposiTrak Reports Slight Decline in Quarterly Revenue but Year-to-Date Growth

ReposiTrak, Inc. reported its financial results for the three and nine months ended March 31, 2026, revealing a slight decline in quarterly revenue but an overall increase in year-to-date performance. The company generated revenue of $5.88 million for the three months ended March 31, 2026, a decrease of 1% from $5.91 million in the same period last year. However, for the nine months ended March 31, 2026, revenue increased by 5% to $17.71 million, compared to $16.85 million for the same period in 2025. The growth in revenue for the nine-month period was attributed to an increase in recurring subscription revenue across all business lines, particularly in compliance and traceability services.

Operating expenses for the three months ended March 31, 2026, totaled $3.63 million, down from $4.10 million in the prior year, marking a 12% reduction. This decrease was primarily due to lower costs associated with services and product support, which fell to $803,353 from $911,693, as well as reduced sales and marketing expenses. The company reported net income of $1.99 million for the quarter, slightly up from $1.97 million in the previous year, resulting in a basic income per share of $0.11, compared to $0.10 in the prior year.

In terms of operational developments, ReposiTrak has focused on enhancing its software offerings to meet the growing regulatory requirements under the Food Safety Modernization Act (FSMA). The company has developed patent-pending technologies aimed at improving traceability data management, which is increasingly critical for its clients in the food supply chain. The company also announced a quarterly cash dividend of $0.02 per share, reflecting its commitment to returning value to shareholders.

As of March 31, 2026, ReposiTrak's total assets stood at $57.38 million, up from $55.33 million at the end of the previous fiscal year. The company reported cash and cash equivalents of $26.41 million, a decrease from $28.57 million as of June 30, 2025. Current liabilities increased to $6.77 million, primarily due to higher accrued liabilities and deferred revenue. The company’s working capital decreased to $26.34 million from $28.15 million, reflecting changes in accounts receivable and prepaid expenses.

Looking ahead, ReposiTrak anticipates continued growth driven by the increasing demand for compliance and traceability solutions in the food industry. The company is focused on expanding its market presence and enhancing its service offerings to meet evolving regulatory standards. Management believes that its existing cash and short-term investments, along with operational cash flow, will be sufficient to support its operational and investment needs for at least the next twelve months.